Nonadherence to Gleevec in GIST patients is common, with cognitive functioning, TDM, and social support as key indicators. A machine learning model using 64 covariates identified 19 significant ...

CHICAGO (Reuters) - An altered version of the cancer drug Gleevec could form the basis of a new class of drugs that block the development of brain-damaging plaques in Alzheimer's disease, U.S.

In 2001, a Time Magazine cover story touted Novartis’ targeted leukemia treatment Gleevec (imatinib) as a new kind of “ammunition in the war against cancer.” Along with a picture of the Gleevec pills, ...

W A S H I N G T O N, June 22 -- Two factors — a geneticmutation and the excessive production of a key enzyme — havecaused some patients with very advanced leukemia to developresistance to the new anti ...

Imatinib is an oral targeted therapy used for several cancers and other conditions caused by specific genetic mutations. The medication is approved for: Philadelphia chromosome positive chronic ...